0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Efinaconazole Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-30N9469
Home | Market Reports | Health| Pharmacy
Global Efinaconazole Market Insights Forecast to 2028
BUY CHAPTERS

Global Efinaconazole Market Insights, Forecast to 2030

Code: QYRE-Auto-30N9469
Report
December 2024
Pages:76
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Efinaconazole Market

Efinaconazole is a 14 alpha-demethylase inhibitor indicated in the treatment of fungal infection of the nail, known as onychomycosis.
The global Efinaconazole market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Efinaconazole is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Efinaconazole is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Efinaconazole is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Efinaconazole include Viruj Pharma and Zhejiang Aoxiang Pharmaceutical etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Efinaconazole, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Efinaconazole, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Efinaconazole, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Efinaconazole sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Efinaconazole market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Efinaconazole sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Efinaconazole Market Report

Report Metric Details
Report Name Efinaconazole Market
Segment by Type
  • Purity Above 98%
  • Purity Below 98%
Segment by Application
  • Onychomycosis
  • Other
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Efinaconazole in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of Efinaconazole manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Efinaconazole sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

What are the Application segmentation covered in the Efinaconazole Market report?

Ans: The Applications covered in the Efinaconazole Market report are Onychomycosis, Other

What are the Type segmentation covered in the Efinaconazole Market report?

Ans: The Types covered in the Efinaconazole Market report are Purity Above 98%, Purity Below 98%

Recommended Reports

Antifungal Drugs

Azole Derivatives

Fungal Disease Treatments

1 Study Coverage
1.1 Efinaconazole Product Introduction
1.2 Market by Type
1.2.1 Global Efinaconazole Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Purity Above 98%
1.2.3 Purity Below 98%
1.3 Market by Application
1.3.1 Global Efinaconazole Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Onychomycosis
1.3.3 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Efinaconazole Sales Estimates and Forecasts 2019-2030
2.2 Global Efinaconazole Revenue by Region
2.2.1 Global Efinaconazole Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Efinaconazole Revenue by Region (2019-2024)
2.2.3 Global Efinaconazole Revenue by Region (2025-2030)
2.2.4 Global Efinaconazole Revenue Market Share by Region (2019-2030)
2.3 Global Efinaconazole Sales Estimates and Forecasts 2019-2030
2.4 Global Efinaconazole Sales by Region
2.4.1 Global Efinaconazole Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Efinaconazole Sales by Region (2019-2024)
2.4.3 Global Efinaconazole Sales by Region (2025-2030)
2.4.4 Global Efinaconazole Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Efinaconazole Sales by Manufacturers
3.1.1 Global Efinaconazole Sales by Manufacturers (2019-2024)
3.1.2 Global Efinaconazole Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Efinaconazole in 2023
3.2 Global Efinaconazole Revenue by Manufacturers
3.2.1 Global Efinaconazole Revenue by Manufacturers (2019-2024)
3.2.2 Global Efinaconazole Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Efinaconazole Revenue in 2023
3.3 Global Key Players of Efinaconazole, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Efinaconazole Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Efinaconazole Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Efinaconazole, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Efinaconazole, Product Offered and Application
3.8 Global Key Manufacturers of Efinaconazole, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Efinaconazole Sales by Type
4.1.1 Global Efinaconazole Historical Sales by Type (2019-2024)
4.1.2 Global Efinaconazole Forecasted Sales by Type (2025-2030)
4.1.3 Global Efinaconazole Sales Market Share by Type (2019-2030)
4.2 Global Efinaconazole Revenue by Type
4.2.1 Global Efinaconazole Historical Revenue by Type (2019-2024)
4.2.2 Global Efinaconazole Forecasted Revenue by Type (2025-2030)
4.2.3 Global Efinaconazole Revenue Market Share by Type (2019-2030)
4.3 Global Efinaconazole Price by Type
4.3.1 Global Efinaconazole Price by Type (2019-2024)
4.3.2 Global Efinaconazole Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Efinaconazole Sales by Application
5.1.1 Global Efinaconazole Historical Sales by Application (2019-2024)
5.1.2 Global Efinaconazole Forecasted Sales by Application (2025-2030)
5.1.3 Global Efinaconazole Sales Market Share by Application (2019-2030)
5.2 Global Efinaconazole Revenue by Application
5.2.1 Global Efinaconazole Historical Revenue by Application (2019-2024)
5.2.2 Global Efinaconazole Forecasted Revenue by Application (2025-2030)
5.2.3 Global Efinaconazole Revenue Market Share by Application (2019-2030)
5.3 Global Efinaconazole Price by Application
5.3.1 Global Efinaconazole Price by Application (2019-2024)
5.3.2 Global Efinaconazole Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Efinaconazole Market Size by Type
6.1.1 US & Canada Efinaconazole Sales by Type (2019-2030)
6.1.2 US & Canada Efinaconazole Revenue by Type (2019-2030)
6.2 US & Canada Efinaconazole Market Size by Application
6.2.1 US & Canada Efinaconazole Sales by Application (2019-2030)
6.2.2 US & Canada Efinaconazole Revenue by Application (2019-2030)
6.3 US & Canada Efinaconazole Market Size by Country
6.3.1 US & Canada Efinaconazole Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Efinaconazole Sales by Country (2019-2030)
6.3.3 US & Canada Efinaconazole Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Efinaconazole Market Size by Type
7.1.1 Europe Efinaconazole Sales by Type (2019-2030)
7.1.2 Europe Efinaconazole Revenue by Type (2019-2030)
7.2 Europe Efinaconazole Market Size by Application
7.2.1 Europe Efinaconazole Sales by Application (2019-2030)
7.2.2 Europe Efinaconazole Revenue by Application (2019-2030)
7.3 Europe Efinaconazole Market Size by Country
7.3.1 Europe Efinaconazole Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Efinaconazole Sales by Country (2019-2030)
7.3.3 Europe Efinaconazole Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Efinaconazole Market Size
8.1.1 China Efinaconazole Sales (2019-2030)
8.1.2 China Efinaconazole Revenue (2019-2030)
8.2 China Efinaconazole Market Size by Application
8.2.1 China Efinaconazole Sales by Application (2019-2030)
8.2.2 China Efinaconazole Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Efinaconazole Market Size by Type
9.1.1 Asia Efinaconazole Sales by Type (2019-2030)
9.1.2 Asia Efinaconazole Revenue by Type (2019-2030)
9.2 Asia Efinaconazole Market Size by Application
9.2.1 Asia Efinaconazole Sales by Application (2019-2030)
9.2.2 Asia Efinaconazole Revenue by Application (2019-2030)
9.3 Asia Efinaconazole Sales by Region
9.3.1 Asia Efinaconazole Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Efinaconazole Revenue by Region (2019-2030)
9.3.3 Asia Efinaconazole Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Efinaconazole Market Size by Type
10.1.1 Middle East, Africa and Latin America Efinaconazole Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Efinaconazole Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Efinaconazole Market Size by Application
10.2.1 Middle East, Africa and Latin America Efinaconazole Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Efinaconazole Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Efinaconazole Sales by Country
10.3.1 Middle East, Africa and Latin America Efinaconazole Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Efinaconazole Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Efinaconazole Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Viruj Pharma
11.1.1 Viruj Pharma Company Information
11.1.2 Viruj Pharma Overview
11.1.3 Viruj Pharma Efinaconazole Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Viruj Pharma Efinaconazole Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Viruj Pharma Recent Developments
11.2 Zhejiang Aoxiang Pharmaceutical
11.2.1 Zhejiang Aoxiang Pharmaceutical Company Information
11.2.2 Zhejiang Aoxiang Pharmaceutical Overview
11.2.3 Zhejiang Aoxiang Pharmaceutical Efinaconazole Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Zhejiang Aoxiang Pharmaceutical Efinaconazole Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Zhejiang Aoxiang Pharmaceutical Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Efinaconazole Industry Chain Analysis
12.2 Efinaconazole Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Efinaconazole Production Mode & Process
12.4 Efinaconazole Sales and Marketing
12.4.1 Efinaconazole Sales Channels
12.4.2 Efinaconazole Distributors
12.5 Efinaconazole Customers
13 Market Dynamics
13.1 Efinaconazole Industry Trends
13.2 Efinaconazole Market Drivers
13.3 Efinaconazole Market Challenges
13.4 Efinaconazole Market Restraints
14 Key Findings in The Global Efinaconazole Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Efinaconazole Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Purity Above 98%
    Table 3. Major Manufacturers of Purity Below 98%
    Table 4. Global Efinaconazole Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 5. Global Efinaconazole Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Efinaconazole Revenue by Region (2019-2024) & (US$ Million)
    Table 7. Global Efinaconazole Revenue by Region (2025-2030) & (US$ Million)
    Table 8. Global Efinaconazole Revenue Market Share by Region (2019-2024)
    Table 9. Global Efinaconazole Revenue Market Share by Region (2025-2030)
    Table 10. Global Efinaconazole Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 11. Global Efinaconazole Sales by Region (2019-2024) & (MT)
    Table 12. Global Efinaconazole Sales by Region (2025-2030) & (MT)
    Table 13. Global Efinaconazole Sales Market Share by Region (2019-2024)
    Table 14. Global Efinaconazole Sales Market Share by Region (2025-2030)
    Table 15. Global Efinaconazole Sales by Manufacturers (2019-2024) & (MT)
    Table 16. Global Efinaconazole Sales Share by Manufacturers (2019-2024)
    Table 17. Global Efinaconazole Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 18. Global Efinaconazole Revenue Share by Manufacturers (2019-2024)
    Table 19. Global Key Players of Efinaconazole, Industry Ranking, 2022 VS 2023 VS 2024
    Table 20. Efinaconazole Price by Manufacturers 2019-2024 (USD/Kg)
    Table 21. Global Efinaconazole Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Efinaconazole by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Efinaconazole as of 2023)
    Table 23. Global Key Manufacturers of Efinaconazole, Manufacturing Base Distribution and Headquarters
    Table 24. Global Key Manufacturers of Efinaconazole, Product Offered and Application
    Table 25. Global Key Manufacturers of Efinaconazole, Date of Enter into This Industry
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Efinaconazole Sales by Type (2019-2024) & (MT)
    Table 28. Global Efinaconazole Sales by Type (2025-2030) & (MT)
    Table 29. Global Efinaconazole Sales Share by Type (2019-2024)
    Table 30. Global Efinaconazole Sales Share by Type (2025-2030)
    Table 31. Global Efinaconazole Revenue by Type (2019-2024) & (US$ Million)
    Table 32. Global Efinaconazole Revenue by Type (2025-2030) & (US$ Million)
    Table 33. Global Efinaconazole Revenue Share by Type (2019-2024)
    Table 34. Global Efinaconazole Revenue Share by Type (2025-2030)
    Table 35. Efinaconazole Price by Type (2019-2024) & (USD/Kg)
    Table 36. Global Efinaconazole Price Forecast by Type (2025-2030) & (USD/Kg)
    Table 37. Global Efinaconazole Sales by Application (2019-2024) & (MT)
    Table 38. Global Efinaconazole Sales by Application (2025-2030) & (MT)
    Table 39. Global Efinaconazole Sales Share by Application (2019-2024)
    Table 40. Global Efinaconazole Sales Share by Application (2025-2030)
    Table 41. Global Efinaconazole Revenue by Application (2019-2024) & (US$ Million)
    Table 42. Global Efinaconazole Revenue by Application (2025-2030) & (US$ Million)
    Table 43. Global Efinaconazole Revenue Share by Application (2019-2024)
    Table 44. Global Efinaconazole Revenue Share by Application (2025-2030)
    Table 45. Efinaconazole Price by Application (2019-2024) & (USD/Kg)
    Table 46. Global Efinaconazole Price Forecast by Application (2025-2030) & (USD/Kg)
    Table 47. US & Canada Efinaconazole Sales by Type (2019-2024) & (MT)
    Table 48. US & Canada Efinaconazole Sales by Type (2025-2030) & (MT)
    Table 49. US & Canada Efinaconazole Revenue by Type (2019-2024) & (US$ Million)
    Table 50. US & Canada Efinaconazole Revenue by Type (2025-2030) & (US$ Million)
    Table 51. US & Canada Efinaconazole Sales by Application (2019-2024) & (MT)
    Table 52. US & Canada Efinaconazole Sales by Application (2025-2030) & (MT)
    Table 53. US & Canada Efinaconazole Revenue by Application (2019-2024) & (US$ Million)
    Table 54. US & Canada Efinaconazole Revenue by Application (2025-2030) & (US$ Million)
    Table 55. US & Canada Efinaconazole Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 56. US & Canada Efinaconazole Revenue by Country (2019-2024) & (US$ Million)
    Table 57. US & Canada Efinaconazole Revenue by Country (2025-2030) & (US$ Million)
    Table 58. US & Canada Efinaconazole Sales by Country (2019-2024) & (MT)
    Table 59. US & Canada Efinaconazole Sales by Country (2025-2030) & (MT)
    Table 60. Europe Efinaconazole Sales by Type (2019-2024) & (MT)
    Table 61. Europe Efinaconazole Sales by Type (2025-2030) & (MT)
    Table 62. Europe Efinaconazole Revenue by Type (2019-2024) & (US$ Million)
    Table 63. Europe Efinaconazole Revenue by Type (2025-2030) & (US$ Million)
    Table 64. Europe Efinaconazole Sales by Application (2019-2024) & (MT)
    Table 65. Europe Efinaconazole Sales by Application (2025-2030) & (MT)
    Table 66. Europe Efinaconazole Revenue by Application (2019-2024) & (US$ Million)
    Table 67. Europe Efinaconazole Revenue by Application (2025-2030) & (US$ Million)
    Table 68. Europe Efinaconazole Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 69. Europe Efinaconazole Revenue by Country (2019-2024) & (US$ Million)
    Table 70. Europe Efinaconazole Revenue by Country (2025-2030) & (US$ Million)
    Table 71. Europe Efinaconazole Sales by Country (2019-2024) & (MT)
    Table 72. Europe Efinaconazole Sales by Country (2025-2030) & (MT)
    Table 73. China Efinaconazole Sales by Type (2019-2024) & (MT)
    Table 74. China Efinaconazole Sales by Type (2025-2030) & (MT)
    Table 75. China Efinaconazole Revenue by Type (2019-2024) & (US$ Million)
    Table 76. China Efinaconazole Revenue by Type (2025-2030) & (US$ Million)
    Table 77. China Efinaconazole Sales by Application (2019-2024) & (MT)
    Table 78. China Efinaconazole Sales by Application (2025-2030) & (MT)
    Table 79. China Efinaconazole Revenue by Application (2019-2024) & (US$ Million)
    Table 80. China Efinaconazole Revenue by Application (2025-2030) & (US$ Million)
    Table 81. Asia Efinaconazole Sales by Type (2019-2024) & (MT)
    Table 82. Asia Efinaconazole Sales by Type (2025-2030) & (MT)
    Table 83. Asia Efinaconazole Revenue by Type (2019-2024) & (US$ Million)
    Table 84. Asia Efinaconazole Revenue by Type (2025-2030) & (US$ Million)
    Table 85. Asia Efinaconazole Sales by Application (2019-2024) & (MT)
    Table 86. Asia Efinaconazole Sales by Application (2025-2030) & (MT)
    Table 87. Asia Efinaconazole Revenue by Application (2019-2024) & (US$ Million)
    Table 88. Asia Efinaconazole Revenue by Application (2025-2030) & (US$ Million)
    Table 89. Asia Efinaconazole Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 90. Asia Efinaconazole Revenue by Region (2019-2024) & (US$ Million)
    Table 91. Asia Efinaconazole Revenue by Region (2025-2030) & (US$ Million)
    Table 92. Asia Efinaconazole Sales by Region (2019-2024) & (MT)
    Table 93. Asia Efinaconazole Sales by Region (2025-2030) & (MT)
    Table 94. Middle East, Africa and Latin America Efinaconazole Sales by Type (2019-2024) & (MT)
    Table 95. Middle East, Africa and Latin America Efinaconazole Sales by Type (2025-2030) & (MT)
    Table 96. Middle East, Africa and Latin America Efinaconazole Revenue by Type (2019-2024) & (US$ Million)
    Table 97. Middle East, Africa and Latin America Efinaconazole Revenue by Type (2025-2030) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Efinaconazole Sales by Application (2019-2024) & (MT)
    Table 99. Middle East, Africa and Latin America Efinaconazole Sales by Application (2025-2030) & (MT)
    Table 100. Middle East, Africa and Latin America Efinaconazole Revenue by Application (2019-2024) & (US$ Million)
    Table 101. Middle East, Africa and Latin America Efinaconazole Revenue by Application (2025-2030) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Efinaconazole Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 103. Middle East, Africa and Latin America Efinaconazole Revenue by Country (2019-2024) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Efinaconazole Revenue by Country (2025-2030) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Efinaconazole Sales by Country (2019-2024) & (MT)
    Table 106. Middle East, Africa and Latin America Efinaconazole Sales by Country (2025-2030) & (MT)
    Table 107. Viruj Pharma Company Information
    Table 108. Viruj Pharma Description and Major Businesses
    Table 109. Viruj Pharma Efinaconazole Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 110. Viruj Pharma Efinaconazole Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Viruj Pharma Recent Developments
    Table 112. Zhejiang Aoxiang Pharmaceutical Company Information
    Table 113. Zhejiang Aoxiang Pharmaceutical Description and Major Businesses
    Table 114. Zhejiang Aoxiang Pharmaceutical Efinaconazole Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)
    Table 115. Zhejiang Aoxiang Pharmaceutical Efinaconazole Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Zhejiang Aoxiang Pharmaceutical Recent Developments
    Table 117. Key Raw Materials Lists
    Table 118. Raw Materials Key Suppliers Lists
    Table 119. Efinaconazole Distributors List
    Table 120. Efinaconazole Customers List
    Table 121. Efinaconazole Market Trends
    Table 122. Efinaconazole Market Drivers
    Table 123. Efinaconazole Market Challenges
    Table 124. Efinaconazole Market Restraints
    Table 125. Research Programs/Design for This Report
    Table 126. Key Data Information from Secondary Sources
    Table 127. Key Data Information from Primary Sources
List of Figures
    Figure 1. Efinaconazole Product Picture
    Figure 2. Global Efinaconazole Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Efinaconazole Market Share by Type in 2023 & 2030
    Figure 4. Purity Above 98% Product Picture
    Figure 5. Purity Below 98% Product Picture
    Figure 6. Global Efinaconazole Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Efinaconazole Market Share by Application in 2023 & 2030
    Figure 8. Onychomycosis
    Figure 9. Other
    Figure 10. Efinaconazole Report Years Considered
    Figure 11. Global Efinaconazole Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Efinaconazole Revenue 2019-2030 (US$ Million)
    Figure 13. Global Efinaconazole Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 14. Global Efinaconazole Revenue Market Share by Region (2019-2030)
    Figure 15. Global Efinaconazole Sales 2019-2030 ((MT)
    Figure 16. Global Efinaconazole Sales Market Share by Region (2019-2030)
    Figure 17. US & Canada Efinaconazole Sales YoY (2019-2030) & (MT)
    Figure 18. US & Canada Efinaconazole Revenue YoY (2019-2030) & (US$ Million)
    Figure 19. Europe Efinaconazole Sales YoY (2019-2030) & (MT)
    Figure 20. Europe Efinaconazole Revenue YoY (2019-2030) & (US$ Million)
    Figure 21. China Efinaconazole Sales YoY (2019-2030) & (MT)
    Figure 22. China Efinaconazole Revenue YoY (2019-2030) & (US$ Million)
    Figure 23. Asia (excluding China) Efinaconazole Sales YoY (2019-2030) & (MT)
    Figure 24. Asia (excluding China) Efinaconazole Revenue YoY (2019-2030) & (US$ Million)
    Figure 25. Middle East, Africa and Latin America Efinaconazole Sales YoY (2019-2030) & (MT)
    Figure 26. Middle East, Africa and Latin America Efinaconazole Revenue YoY (2019-2030) & (US$ Million)
    Figure 27. The Efinaconazole Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 28. The Top 5 and 10 Largest Manufacturers of Efinaconazole in the World: Market Share by Efinaconazole Revenue in 2023
    Figure 29. Global Efinaconazole Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 30. Global Efinaconazole Sales Market Share by Type (2019-2030)
    Figure 31. Global Efinaconazole Revenue Market Share by Type (2019-2030)
    Figure 32. Global Efinaconazole Sales Market Share by Application (2019-2030)
    Figure 33. Global Efinaconazole Revenue Market Share by Application (2019-2030)
    Figure 34. US & Canada Efinaconazole Sales Market Share by Type (2019-2030)
    Figure 35. US & Canada Efinaconazole Revenue Market Share by Type (2019-2030)
    Figure 36. US & Canada Efinaconazole Sales Market Share by Application (2019-2030)
    Figure 37. US & Canada Efinaconazole Revenue Market Share by Application (2019-2030)
    Figure 38. US & Canada Efinaconazole Revenue Share by Country (2019-2030)
    Figure 39. US & Canada Efinaconazole Sales Share by Country (2019-2030)
    Figure 40. U.S. Efinaconazole Revenue (2019-2030) & (US$ Million)
    Figure 41. Canada Efinaconazole Revenue (2019-2030) & (US$ Million)
    Figure 42. Europe Efinaconazole Sales Market Share by Type (2019-2030)
    Figure 43. Europe Efinaconazole Revenue Market Share by Type (2019-2030)
    Figure 44. Europe Efinaconazole Sales Market Share by Application (2019-2030)
    Figure 45. Europe Efinaconazole Revenue Market Share by Application (2019-2030)
    Figure 46. Europe Efinaconazole Revenue Share by Country (2019-2030)
    Figure 47. Europe Efinaconazole Sales Share by Country (2019-2030)
    Figure 48. Germany Efinaconazole Revenue (2019-2030) & (US$ Million)
    Figure 49. France Efinaconazole Revenue (2019-2030) & (US$ Million)
    Figure 50. U.K. Efinaconazole Revenue (2019-2030) & (US$ Million)
    Figure 51. Italy Efinaconazole Revenue (2019-2030) & (US$ Million)
    Figure 52. Russia Efinaconazole Revenue (2019-2030) & (US$ Million)
    Figure 53. China Efinaconazole Sales Market Share by Type (2019-2030)
    Figure 54. China Efinaconazole Revenue Market Share by Type (2019-2030)
    Figure 55. China Efinaconazole Sales Market Share by Application (2019-2030)
    Figure 56. China Efinaconazole Revenue Market Share by Application (2019-2030)
    Figure 57. Asia Efinaconazole Sales Market Share by Type (2019-2030)
    Figure 58. Asia Efinaconazole Revenue Market Share by Type (2019-2030)
    Figure 59. Asia Efinaconazole Sales Market Share by Application (2019-2030)
    Figure 60. Asia Efinaconazole Revenue Market Share by Application (2019-2030)
    Figure 61. Asia Efinaconazole Revenue Share by Region (2019-2030)
    Figure 62. Asia Efinaconazole Sales Share by Region (2019-2030)
    Figure 63. Japan Efinaconazole Revenue (2019-2030) & (US$ Million)
    Figure 64. South Korea Efinaconazole Revenue (2019-2030) & (US$ Million)
    Figure 65. China Taiwan Efinaconazole Revenue (2019-2030) & (US$ Million)
    Figure 66. Southeast Asia Efinaconazole Revenue (2019-2030) & (US$ Million)
    Figure 67. India Efinaconazole Revenue (2019-2030) & (US$ Million)
    Figure 68. Middle East, Africa and Latin America Efinaconazole Sales Market Share by Type (2019-2030)
    Figure 69. Middle East, Africa and Latin America Efinaconazole Revenue Market Share by Type (2019-2030)
    Figure 70. Middle East, Africa and Latin America Efinaconazole Sales Market Share by Application (2019-2030)
    Figure 71. Middle East, Africa and Latin America Efinaconazole Revenue Market Share by Application (2019-2030)
    Figure 72. Middle East, Africa and Latin America Efinaconazole Revenue Share by Country (2019-2030)
    Figure 73. Middle East, Africa and Latin America Efinaconazole Sales Share by Country (2019-2030)
    Figure 74. Brazil Efinaconazole Revenue (2019-2030) & (US$ Million)
    Figure 75. Mexico Efinaconazole Revenue (2019-2030) & (US$ Million)
    Figure 76. Turkey Efinaconazole Revenue (2019-2030) & (US$ Million)
    Figure 77. Israel Efinaconazole Revenue (2019-2030) & (US$ Million)
    Figure 78. GCC Countries Efinaconazole Revenue (2019-2030) & (US$ Million)
    Figure 79. Efinaconazole Value Chain
    Figure 80. Efinaconazole Production Process
    Figure 81. Channels of Distribution
    Figure 82. Distributors Profiles
    Figure 83. Bottom-up and Top-down Approaches for This Report
    Figure 84. Data Triangulation
    Figure 85. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart